August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS73
Academic Journal
Presents an abstract of the research manuscript `Ploidy and p53 expression in helicobacter pylori (HP) associated gastritis and carcinoma,' by W.A. Mourad et al.


Related Articles

  • The Investigation of p53 and Ki-67 Gene Mutations in Relation with Helicobacter pylori Infection in Patients with Gastric Cancer. Rezaii, J.; Ashegh, H.; Hasibi, M.; Behzadi, M.; Khodadadi, F.; Heidarali, M. // Journal of Medical Sciences;2008, Vol. 8 Issue 6, p564 

    The aim of this study was to evaluate the role of Helicobacter pylori infection in relation with p53 and Ki-67 mutations in a case-control study in Iran, an endemic region for H. pylori infection. Sixty nine cases with gastric cancer and 96 cancer-free control subjects with either gastric ulcer...

  • The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. Nayoung Kim; Sung-Il Cho; Hye Seung Lee; Ji Hyun Park; Jee Hyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song; Kim, Nayoung; Cho, Sung-Il; Lee, Hye Seung; Park, Ji Hyun; Kim, Jee Hyun; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung // Digestive Diseases & Sciences;Jan2010, Vol. 55 Issue 1, p101 

    The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest. The purpose of this study was to evaluate the association of p53 codon 72 genetic polymorphism and the p53 immunohistochemistry with Helicobacter pylori-associated...

  • Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. Murakami, Kazunari; Fujioka, Toshio; Kodama, Masaaki; Honda, Shoji; Okimoto, Tadayoshi; Oda, Touta; Nishizono, Akira; Sato, Ryugo; Kubota, Toshihiro; Kagawa, Jiro; Nasu, Masaru // Journal of Gastroenterology;2002 Supplement 13, Vol. 37, p1 

    Background. p53 gene mutations are believed to play a critical role in the development of gastric carcinoma. We examined the relation between Helicobacter pylori infection and p53 gene mutations of the gastric mucosa in human and animal models. Methods. To detect the original p53 DNA sequences...

  • p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line. Badie, C; Bourhis, J; Sobczak-Th├ępot, J; Haddada, H; Chiron, M; Janicot, M; Janot, F; Tursz, T; Vassal, G // British Journal of Cancer;2/1/2000, Vol. 82 Issue 3, p642 

    In vivo transfer of wild-type (wt) p53 gene via a recombinant adenovirus has been proposed to induce apoptosis and increase radiosensitivity in several human carcinoma models. In the context of combining p53 gene transfer and irradiation, we investigated the consequences of adenoviral-mediated...

  • p53 in Mammary ductal carcinoma in situ, mutations in high-grade lesions only? Simpson, Jean F.; Page, David L.; Edgerton, Mary E.; Simpson, J F; Page, D L; Edgerton, M E // JNCI: Journal of the National Cancer Institute;5/2/2001, Vol. 93 Issue 9, p666 

    Editorials. Comments on the study of p53 tumor suppressor gene in mammary ductal carcinoma in situ (DCIS). Data from invasive carcinoma; Difficulty in the study of the natural history of DCIS; Focus on DCIS in the molecular progression of breast cancer; Understanding of the biology of the...

  • Cancer: Parc keeper. Frantz, Simon // Nature Reviews Drug Discovery;Mar2003, Vol. 2 Issue 3, p174 

    Discusses the role of p53-associated, parkin-like cytoplasmic protein in pathophysiology of cancer. Cytoplasmic levels of p53 in tumor cells; Degradation of protein; Cytoplasmic sequestration.

  • Ovarian cancer linked to p53 gene. Mayor, Susan // BMJ: British Medical Journal (International Edition);07/12/97, Vol. 315 Issue 7100, p77 

    Discusses the possibility that ovarian cancers may be linked to mutations of the regulatory gene p53. Role of ovulation in the development of p53 mutations.

  • Loss of p53-immunostaining intensity in breast cancer. Henson, Donald E. // JNCI: Journal of the National Cancer Institute;08/07/96, Vol. 88 Issue 15, p1015 

    Editorial. Comments on the impact of lost immunostaining intensity of the P53 antioncogene in treating breast cancer. Amount of immunoreactivity lost after two weeks storage on unstained glass slides; Chemicals and stain preparation procedures suspected for the lost immunostaining capacity of...

  • Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. Jacobs, Timothy W.; Prioleau, John E. // JNCI: Journal of the National Cancer Institute;08/07/96, Vol. 88 Issue 15, p1054 

    Discusses the decrease in the immunostaining properties of the P53 antioncogenes in slides of breast cancer samples. Theories linking environmental storage conditions and slide preparation chemicals to immunostaining loss; Progress of the decline in staining intensity after two weeks.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics